Výsledky vyhledávání - "Ana Cavillon"

Reply to Binghao Zhao, Ruidong Zhang, and Jiaming Wu’s Letter to the Editor re: Ana Cavillon, Damien Pouessel, Nadine Houédé, et al. Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.02.011

Autor: Ana Cavillon, Raphael Porcher, Thomas Filleron

Publikováno v: European Urology.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e1fdde0e21f4b86d98638916c40d6f44
https://doi.org/10.1016/j.eururo.2023.04.016

Zobrazit plný text záznamu

Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor Trials

Autor: Ana Cavillon, Damien Pouessel, Nadine Houédé, Fanny Mathevet, Jean Yves Dauxois, Christine Chevreau, Stéphane Culine, Jean-Pierre Delord, Raphael Porcher, Thomas Filleron

Publikováno v: European Urology
European Urology, 2023, pp.1-8. ⟨10.1016/j.eururo.2023.02.011⟩

International audience; BackgroundThe Keynote-045 trial illustrates that the long-term benefit (LTB) of treatment does not always translate to improved progression-free survival (PFS). Milestone survival and flexible parametric survival model with cu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e4689d6c7882a50829a075a9c89a0e
https://hal-cnam.archives-ouvertes.fr/hal-04086906

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání